ArticleDrug delivery and translational research2026

A phase I clinical study to evaluate rapid, high-volume, subcutaneous auto-injector tolerability with recombinant human hyaluronidase.

David W Kang et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.